Zatula D G
Neoplasma. 1984;31(1):65-74.
By means of metabolic products of the AB-56 strain of Bac. mesentericus it was possible to produce specific antitumor vaccines which both in experimental and clinical conditions proved to have prophylactic and therapeutic effects. 60-100% of the animals prophylactically immunized with these vaccines became resistant to a subsequent injection of living virulent cells, the percentage depending on the number of immunizations. The employment of similar autovaccines in the treatment of relapses and metastases in humans resulted in a 56% five-year survival of patients operated on for gastric cancer, in contrast to a 28% five-year survival of those without any vaccination.
借助肠系膜芽孢杆菌AB - 56菌株的代谢产物，有可能生产出特异性抗肿瘤疫苗，实验和临床条件均证明其具有预防和治疗作用。用这些疫苗进行预防性免疫的动物中，60% - 100%对随后注射的活毒细胞产生了抗性，该百分比取决于免疫次数。在治疗人类复发和转移时使用类似的自身疫苗，胃癌手术患者的五年生存率为56%，而未进行任何疫苗接种的患者五年生存率为28%。
